Risultati della ricerca - E. Ferrant

219 | PATIENT REPORTED OUTCOMES FROM BRUIN CLL‐321: PHASE 3 TRIAL COMPARING PIRTOBRUTINIB TO IDELALISIB/RITUXIMAB OR BENDAMUSTINE/RITUXIMAB IN COVALENT BTKi PRETREATED CLL/SLL di P. Barr, P. Ghia, D. Rossi, E. Ferrant, F. De la Cruz Vicente, D. Maruyama, V. Banerji, P. Cobb, S. Namburi, R. Greil, A. Loubert, K. Creel, L. M. Hess, N. Payakachat, A. S. Ruppert, D. Wang, P. Abada, C. C. Leow, M. Hill, C. C. Coombs, J. P. Sharman

Testo